Roy M. Pollock,Scott R. Daigle,Eric Hedrick,Nigel Waters,Blythe Thomson
申请号：
US15036544
公开号：
US20160296548A1
申请日:
2014.11.13
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
